Retention in the National Institute on Drug Abuse Clinical Trials Network Women and Trauma Study: Implications for Posttrial Implementation

Rogério M. Pinto, Aimee N.C. Campbell, Denise A. Hien, Gary Yu, Prakash Gorroochurn

Research output: Contribution to journalArticle

Abstract

This study aimed to identify factors that influenced retention in the National Institute on Drug Abuse-funded Women and Trauma Study, conducted within the Clinical Trials Network (CTN). Women (N=346) were recruited from and received treatment in 6 CTN-affiliated sites. Log-linear and logistic models were used to explore factors associated with retention. The mean number of treatment sessions attended was 6.8 (SD= 3.9). Women with more education, higher attendance at 12-step meetings, and strong therapeutic alliance between facilitator and participant had better retention rates. Significant site differences were found; the site with the highest retention rate provided child care and had the lowest average monthly intake. To retain women with histories of trauma and substance abuse in "real world" psychiatric settings, emphasis on regulating individual-level and site-related modifiable variables are crucial.

Original languageEnglish (US)
Pages (from-to)211-217
Number of pages7
JournalAmerican Journal of Orthopsychiatry
Volume81
Issue number2
DOIs
StatePublished - Apr 2011

Keywords

  • Community-based treatment
  • Randomized clinical trials
  • Retention
  • Substance abuse
  • Trauma
  • Women

ASJC Scopus subject areas

  • Developmental and Educational Psychology
  • Arts and Humanities (miscellaneous)
  • Psychology (miscellaneous)
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Retention in the National Institute on Drug Abuse Clinical Trials Network Women and Trauma Study: Implications for Posttrial Implementation'. Together they form a unique fingerprint.

  • Cite this